STOCK TITAN

ICU Medical's Greenberg exercises options, sells 883 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

ICU Medical director David C. Greenberg exercised 883 non-qualified stock options at $158.20 per share on November 20, 2026, acquiring 883 common shares. He also sold 883 shares at $176.12 per share; a footnote identifies the securities sold as Restricted Stock Units. The report lists 882 options remaining after the exercise and 500 shares held indirectly through a trust. No Rule 10b5-1 plan is reported.

Insider Greenberg David C.
Role Director
Sold 883 shs ($156K)
Approx. gross sale proceeds $156K
Approx. exercise cost $140K
Approx. pre-tax spread $16K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 883 $0.00 $0.00
Exercise Common Stock 883 $158.20 $140K
Sale Common Stock F1, F2 883 $176.12 $156K
Holding Common Stock -- -- --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 882 options (Direct); Common Stock — 9,214 shares (Direct); Common Stock — 500 shares (Indirect, by Trust)
Footnotes (2)
  1. F1. These securities are Restricted Stock Units.
  2. F2. All shares sold were sold at the exact price disclosed.
Options exercised 883 options November 20, 2026
Exercise price $158.20 per share Options exercised November 20, 2026
Shares sold 883 shares November 20, 2026
Sale price $176.12 per share November 20, 2026
Options remaining 882 options Following the exercise
Shares held through a trust 500 shares Reported as held indirectly
Non-Qualified Stock Option (right to buy) technical
"883 Non-Qualified Stock Option (right to buy)"
Restricted Stock Units technical
"These securities are Restricted Stock Units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did the ICU Medical director exercise, and at what price?

David C. Greenberg exercised 883 non-qualified stock options at $158.20 per share on November 20, 2026. The report lists 882 options remaining after the exercise.

How many shares did the ICU Medical director sell, and at what price?

David C. Greenberg sold 883 shares at $176.12 per share on November 20, 2026. A footnote identifies the securities sold as Restricted Stock Units. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greenberg David C.

(Last)(First)(Middle)
951 CALLE AMANECER

(Street)
SAN CLEMENTE CALIFORNIA 92673

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/20/2026M883A$158.210,097D
Common Stock(1)11/20/2026S883D$176.12(2)9,214D
Common Stock500Iby Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$158.211/20/2026M88305/09/201805/09/2027Common Stock883$0.0882D
Explanation of Responses:
1. These securities are Restricted Stock Units.
2. All shares sold were sold at the exact price disclosed.
By: Paula Darbyshire, Attorney-in-Fact For: David C. Greenberg11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading